Primary Antibodies
Secondary Antibodies
Proteins & Peptides
ELISA Kits
About Us
Contact Us
Antibodies.com Logo Antibodies.com Logo
Sign In/Register
0
ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Recombinant Anti-VSIG4 Antibody [DMC268] (PE) (A334360)

Antibodies.com Image Placeholder - Discover more for less
Antibodies.com Image Placeholder - Discover more for less
Recombinant Antibody
$1,001
Product Datasheet

Recombinant chimeric monoclonal [DMC268] antibody to VSIG4 (PE) for Flow Cytometry.

100% Guarantee
Price Match Guarantee
Request a Quotation
Custom or Bulk Request

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.

  • Specifications

Name
Anti-VSIG4 Antibody [DMC268] (PE)
Description
Recombinant chimeric monoclonal [DMC268] antibody to VSIG4 (PE).
Applications
Flow Cytometry
Dilutions
Flow Cytometry: 1:100
Reactivity
Human
Host
Rabbit / Human
Clonality
Monoclonal
Clone ID
DMC268
Isotype
IgG1
Conjugate

PE

Excitation: 565nm, Emission: 578nm

Purification
Affinity chromatography.
Concentration
Lot Specific
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 0.05% Proclin 300 and 1% BSA.
Storage
Store at 4°C. Do not freeze!
General Notes
This antibody is a recombinant rabbit chimeric monoclonal antibody containing human IgG1 Fc.
Synonyms
CRIg, Protein Z39Ig, V-set and immunoglobulin domain-containing protein 4, Z39IG
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Recombinant Anti-VSIG4 Antibody [DMC268] (PE) (A334360)? Please let us know so that we can list the citation on this page.

Proteins predicted to interact with VSIG4

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
97.1% Relevancy Score
96.1% Relevancy Score
95.8% Relevancy Score
94.3% Relevancy Score
93.8% Relevancy Score
85.9% Relevancy Score
83.7% Relevancy Score
78.3% Relevancy Score